Product NDC: | 62856-177 |
Proprietary Name: | Gliadel |
Non Proprietary Name: | polifeprosan 20 with carmustine implant |
Active Ingredient(s): | 7.7 mg/1 & nbsp; polifeprosan 20 with carmustine implant |
Administration Route(s): | INTRACAVITARY |
Dosage Form(s): | WAFER |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 62856-177 |
Labeler Name: | Eisai Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020637 |
Marketing Category: | NDA |
Start Marketing Date: | 19960924 |
Package NDC: | 62856-177-08 |
Package Description: | 8 POUCH in 1 BOX (62856-177-08) > 1 WAFER in 1 POUCH |
NDC Code | 62856-177-08 |
Proprietary Name | Gliadel |
Package Description | 8 POUCH in 1 BOX (62856-177-08) > 1 WAFER in 1 POUCH |
Product NDC | 62856-177 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | polifeprosan 20 with carmustine implant |
Dosage Form Name | WAFER |
Route Name | INTRACAVITARY |
Start Marketing Date | 19960924 |
Marketing Category Name | NDA |
Labeler Name | Eisai Inc. |
Substance Name | CARMUSTINE |
Strength Number | 7.7 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Alkylating Activity [MoA],Alkylating Drug [EPC] |